Halozyme (RV7) Financial Statements

0 Followers

Halozyme Financial Overview

Halozyme's market cap is currently CHF10.14B. The company's EPS TTM is CHF3.52; its P/E ratio is 31.30; Halozyme is scheduled to report earnings on August 6, 2026, and the estimated EPS forecast is CHF1.83. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 1.40B	$ 1.02B	$ 829.25M	$ 660.12M	$ 443.31M
Gross Profit	$ 1.09B	$ 855.91M	$ 636.89M	$ 520.81M	$ 361.90M
Operating Income	$ 816.29M	$ 551.48M	$ 337.57M	$ 267.53M	$ 275.90M
EBITDA	$ 573.05M	$ 656.54M	$ 451.95M	$ 315.51M	$ 259.04M
Net Income	$ 316.89M	$ 444.09M	$ 281.59M	$ 202.13M	$ 402.71M
Balance Sheet
Cash & Short-Term Investments	$ 142.82M	$ 596.07M	$ 336.00M	$ 362.79M	$ 740.92M
Total Assets	$ 2.53B	$ 2.06B	$ 1.73B	$ 1.84B	$ 1.10B
Total Debt	$ 2.14B	$ 1.51B	$ 1.50B	$ 1.51B	$ 876.67M
Net Debt	$ 2.01B	$ 1.39B	$ 1.38B	$ 1.27B	$ 757.96M
Total Liabilities	$ 2.48B	$ 1.70B	$ 1.65B	$ 1.67B	$ 907.48M
Stockholders' Equity	$ 48.81M	$ 363.82M	$ 83.81M	$ 169.80M	$ 196.95M
Cash Flow
Free Cash Flow	$ 644.59M	$ 468.37M	$ 373.28M	$ 235.30M	$ 297.98M
Operating Cash Flow	$ 651.56M	$ 479.06M	$ 388.57M	$ 240.11M	$ 299.44M
Investing Cash Flow	$ -545.81M	$ -262.72M	$ -96.91M	$ -487.00M	$ -406.29M
Financing Cash Flow	$ -85.17M	$ -218.86M	$ -407.99M	$ 362.37M	$ 77.86M

Currency in USD

Halozyme Earnings and Revenue History

Income Statement >

Halozyme Debt to Assets

Balance Sheet >

Halozyme Cash Flow

Cash Flow >

Halozyme Forecast EPS vs Actual EPS

Earnings >